1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117
Email jamie-miller@ouhsc.edu
Publications & Presentations
- 1. Moore B, Johnson P N, Miller J L. A Structured Approach to Identifying and Addressing Drug Therapy Problems in Neonatal and Pediatric Critically Ill Patients: IN-DEPTH. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2025; 30 : 696-704
2. McLarty T, Miller J L, Lewis T V, Neely S, Johnson P N. Evaluation of Research and Scholarship Activities with a Pediatric Curricular Track in a Doctor of Pharmacy Program. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2025; 30 : 607-616
3. Makoni M M, Sierra-Strum I, Bischoff A R, Miller J L, DeShea L, Beasley W H, Szyld E. Dexmedetomidine's effect on neonatal sedation, pain, respiratory status and cardiovascular system. Journal of perinatology : official journal of the California Perinatal Association. 2025
4. Ailumerab H, Miller J L, DeShea L, Beasley W H, Chaaban H, Bergner E M. Risk factors associated with the development of necrotizing enterocolitis in preterm infants on an exclusive human milk diet: a single-center case-control study. Journal of perinatology : official journal of the California Perinatal Association. 2025
5. Johnson P N, Ropp D L, Ranallo C, Chaaban H, Garcia-Contreras L, Neely S, Miller J L. Inhaled Tobramycin Usage in Critically Ill Pediatric Patients Without Cystic Fibrosis: A Pediatric Pharmacy-Association, Practice-Based Research Network Survey Study. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2025; 30 : 332-339
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.
2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.
3. American Society of Health-System Pharmacists. Fellow of American Society of Health-System Pharmacists. Date: 2024.
4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
5. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.